Of these patients, 59 (79.7%) in the PCOS group and 38 (80.9%) in the non-PCOS group had 25(OH)D testing; 52 (71.3%) in the PCOS and 23 (48.9%) in the non-PCOS group had AMH testing (Fig. 1). Here, AMH is linked to polycystic ovary syndrome.